Explore more publications!

Electronics Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Electronics Press Releases.

Press releases published on October 8, 2025

Raiiz Partners with Surgically Clean Air® to Enhance Healthy & Sustainable Homes with Commercial-Grade Air Purification
ZUGU Marks 15 Years with the Launch of Its Most Ambitious iPad Case Yet: The 360 Case
Setting the Mood: How Audio Systems Transform Home Gatherings and Events
Fujiiryoki Launches Official U.S. Online Store, Bringing Premium Japanese Wellness Direct to Consumers
Olympia Lighting to Showcase Advanced Stadium and Sports LED Fixtures at the Athletic Business Show 2025
Transform an Onboard TVs into Advanced Marine Infotainment System
CEO Zak Gardezy: Wealthstone Surpasses 100% AUM Growth Milestone in Just 12 Months
Smart Home Hardware Market Navigating Business with CAGR of 12% with Revenue of $213.6 billion by 2032
RFID Tags Market Predicted to Hit USD 15 billion by 2032, with a 9.9% CAGR
Infrared Sensor Market Size USD 1.17 Billion in 2024 – Growth & Trends 2032
TierOne to Showcase NaaS CX, Smart NOC, and NaaS NOC Solutions at GITEX 2025
Optical Zonu Announces Its Unmanned Aircraft System RFoF Solutions
STMicroelectronics powers 48V mild-hybrid efficiency with flexible automotive 8-channel gate driver
AVer Debuts VB150 4K Video Bar for Effortless AI Meeting Collaboration
Google’s 'AI Home' Moment Proves the Future We’ve Been Building All Along
Nilo Therapeutics startet mit einer Serie-A-Finanzierung in Höhe von 101 Mio. USD zur Entwicklung einer neuen Medikamentenklasse, die auf neuronale Schaltkreise bei Immunerkrankungen abzielt, und ernennt Kim Seth zum Chief Executive Officer
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…
Nilo Therapeutics מושקה עם מימון סדרה A של 101 מיליון דולר לקידום סוג חדש של תרופות המכוונות למעגלים עצביים במחלות חיסוניות וממנה את קים סת' למנכ"ל
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions